J Otolaryngol Ophthalmol Shandong Univ ›› 2017, Vol. 31 ›› Issue (2): 90-95.doi: 10.6040/j.issn.1673-3770.0.2016.146

Previous Articles     Next Articles

Effects of PGMS on the expression of vascular endothelial growth factor in the rat of diabetic retinopathy.

  

  1. 1. Department of Ophthalmology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China;2. Department of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China;3. Eye Center of Shandong University of Traditional Chinese Medicine, Shandong Shierming Eye Hospital, Jinan 250002, Shandong, China
  • Received:2016-04-01 Online:2017-04-16 Published:2017-04-16

PDF (PC)

671

Abstract: Objective To investigate the influence of propylene glycol mannate sulfate(PGMS)on the expression of vascular endothelial growth factor(VEGF)in diabetic retinopathy(DR)by a rat model, to study the mechanism of PGMS againstDR, and to provide a reliable theoretical and experimental evidence for the PGMs to be applied to clinical prevention and treatment of DR. Methods Male Wistar rats were randomized into the normal control group, the diabetic control group and the PGMS group. The PGMS group was subdivided into the low-dose PGMS group and high-dose PGMS group, with doses of 50 mg/kg and 100 mg/kg, respectively. The 1% Streptozotocin(STZ)of 60 mg/kg was intraperitoneally injected in rats to establish the diabetic models. The PGMS with the doses of 50 mg/kg and 100 mg/kg were used to gavage in different groups of models for 12 weeks. Twelve weeks later, the animals were sacrificed and retinas were isolated. The aqueous humor and serum were taken, expressions of VEGF protein in retina, aqueous humor and serum were detected by ELISA, respectively. The location and the expression of VEGF protein in 山东大学耳鼻喉眼学报31卷2期 -周玮琰,等.甘糖酯对糖尿病大鼠视网膜病变中血管生成因子VEGF表达的影响 \=-retina tissue was detected by immune-histochemistry. Real-time RT-PCR was used to measure the expression of VEGF mRNA in retinas. Results Twelve weeks after the use of PGMS,the level of blood glucose was not changed. ELISA showed that the expression of VEGF protein in serum was not significantly changed in different groups(P>0.05), but the expression of VEGF protein in aqueous humor and retina was significantly increased in diabetic control group than normal control group(P<0.05), but the groups which PGMS was given reduced, lower than that DM group, showing statistically significant differences(P<0.05). Immunohistochemistry showed that the VEGF protein was almost not expressed in normal control group, but the VEGF protein was highly expressed in diabetic control group. The expression mainly located in the ganglion cell layer, the inner plexiform layer, outer nuclear layer. The VEGF protein was weakly expressed at the group of PGMS. Real-time RT-PCR showed the expression of VEGF mRNA was lower in normal control group. The expression of VEGF mRNA in diabetic control group was almost 2.12 times than normal control group. The expression was decreased obviously in the group of PGMS. Conclusion PGMs has a good control effect on early diabetic retinopathy. PGMS can treat the diabetic retinopathy by downregulating the expressions of VEGF in early diabetic retinopathy.

Key words: Diabetic retinopathy, Vascular endothelial growth factor, Propylene glycol mannate sulfate

CLC Number: 

  • R774
[1] Osaadon P, Fagan XJ, Lifshitz T, et al. A review of anti-VEGF agents for proliferative diabetic retinopathy[J]. Eye(Lond), 2014, 28(5):510-520.
[2] Cancarini A, Costagliola C, Dell'omo R, et al. Effect of intravitreal bevacizumab on serum, aqueous, and vitreous humor levels of erythropoietin in patients with proliferative diabetic retinopathy[J]. Minerva Endocrinol, 2014, 39(4):305-311.
[3] 巨丹. 甘糖酯对Ⅰ型糖尿病治疗前后血脂、血液流变学变化[J]. 中国血液流变学杂志, 2004, 14(2):198-216.
[4] 王哲, 初奎臣, 高聆, 等. 甘糖酯对实验糖尿病大鼠粘附分子-CD54、CD106、CD62P的影响[J].中国海洋药物, 2003, 22(3):43-47. WANG Zhe, CHU Kuichen, GAO Ling, et al. Effects of Propylene Glycol Mannate Sulfate on Adhesion Mole- CUles-Cd54、 cd106、 cd62pin Diabetic Rats[J]. Chin J Marine Drugs, 2003, 22(3):43-47.
[5] 孔磊, 高聆, 赵家军. 2型糖尿病患者外周血粘附分子变化及甘糖酯干预治疗的初步研究[J]. 山东医药, 2002, 42(5):1-3. KONG Lei, GAO Ling, ZHAO Jiajun. Determination of adhesion molecules in patients with type 2 diabetes mellitus and primary study of curative effect of propylene glycol mannate sulfate[J]. Shandong Med J, 2002, 42(5):1-3.
[6] 王汝霞, 胡建廷, 高聆, 等. 甘糖酯降低实验性糖尿病大鼠肾脏ICAM-1,VCAM-1表达[J]. 中国海洋药物, 2005, 24(1):10-16. WANG Ruxia, HU Jianting, GAO Ling, et al. Propylene glycol mannate sulfate down-regulated the expression of adhesion molecules(icam-1, vcam-1)in kidney of diabetic rats[J]. Chin J Marine Drugs, 2005, 24(1):10-16.
[7] 陈晓, 路新枝, 高焱, 等. 甘糖酯抗氧化作用的分子机制[J]. 药学学报, 2004, 39(1):13-16. CHEN Xiao, LU Xinzhi, GAO Yan, et al. Molecular mechanisms of antioxidant effects of propylene glycol mannate sulfate[J]. Acta Pharmaceutica Sinica, 2004, 39(1):13-16.
[8] 张平, 夏泉, 赵新民. 甘糖酯的药理及临床应用研究进展[J]. 江苏药学与临床研究, 2001, 9(1):36-38.
[9] 滕继军. 甘糖酯对急性脑梗死病人中性粒细胞与内皮细胞黏附的影响[J]. 青岛大学医学院学报, 2003, 39(2):159-160. TENG Jijun. The effect of propylene glyco mannate sulfate on the adhesion between endothelial cells and polymorphonuclear neutrophils in acute cerebral infarction[J]. Acta Acad Med Qingdao Univ, 2003, 39(2):159-160.
[10] 张万科, 欧阳林旗, 罗志彪. 海洋藻类药物研究进展[J]. 海南医学, 2007, 18(6):123-124.
[11] Osaadon P, Fagan XJ, Lifshitz T, et al. A review of anti-VEGF agents for proliferative diabetic retinopathy[J]. Eye(Lond), 2014, 28(5):510-520.
[12] 许宇, 朱颖, 张琦, 等. 增生性糖尿病性视网膜病变围手术期Bevacizumab(Avastin)的应用[J]. 山东大学耳鼻喉眼学报,2010, 24(4):64-67. XU Yu, ZHU Ying, ZHANG Qi, et al. Preoperative use of intravitreal bevacizumab(avastin)for severe active proliferative diabetic retinopathy[J]. J Otolaryngol Ophthalmol Shandong Univ, 2010, 24(4):64-67.
[13] Abu El-Asrar A M, Nawaz M I, Kangave D, et al. Angiogenic and vasculogenic factors in the vitreous from patients with proliferative diabetic retinopathy[J]. Acta Diabetol, 2013, 50(4):545-551.
[14] 谢丽. 糖尿病性黄斑水肿的治疗进展[J]. 山东大学耳鼻喉眼学报,2013,27(2):185-188. XIE Li. Treatment progress of diabetic macular edema[J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(2):81-85.
[15] Semeraro F, Cancarini A, Morescalchi F, et al. Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients withtype 2 diabetes and proliferative retinopathy[J]. Diabetes Metab, 2014, 40(6):445-451.
[16] Mohan N, Monickaraj F, Balasubramanyam M, et al. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy[J]. J Diabetes Complications, 2012, 26(5):435-441.
[17] Ahn J, Woo SJ, Chung H, et al. The effect of adjunctive intravitreal bevacizumab for preventing post vitrectomy hemorrhage in proliferative diabetic retinopathy[J]. Ophthalmol, 2011, 118(11):2218-2226.
[18] 祝敏燕,韩丽荣. 糖尿病视网膜病变血浆与眼内液血管内皮生长因子的相关研究[J]. 中华眼底病杂志, 2004,20(6):343-345. ZHU Minyan, HAN Lirong. Investigation of concentration of vascular endothelial growth factor in plasma and intraocular liquid in diabetic retinopathy[J]. Chin J Ocular Fundus Dis, 2004, 20(6):343-345.
[19] Tuuminen R, Sahanne S, Loukovaara S. Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment[J]. Acta Ophthalmol, 2014, 92(7):675-681.
[1] ZHAO Juan, JIAO Wanzhen, ZHAO Bojun. Assessment of fundus microcirculation changes in diabetic retinopathy using UWFSS-OCTA [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(2): 80-86.
[2] ZHU Mingqiong, LI Zheng, LIU Ru, TIAN Tao, PENG Jingli, LYU Qianyi, TAN Huaxia. The application of AI screening system based on OCT/OCTA in the evaluation of the effect of anti VEGF treatment in patients with diabetes macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 68-73.
[3] SUN Qingzhu, SHEN Jian, CHEN Xing, WU Yanbing, ZENG Lun. The role of metabolic indicators in predicting ranibizumab efficacy in diabetic macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 74-81.
[4] XIN Meng, JI Fang, DAI Chunhua, ZHANG Jing, LIU Shu. Effect of sodium hyaluronate and balanced salt solution on ocular surface protection during minimally invasive vitreorentinal surgery [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 58-65.
[5] CHANG Weiwei, JIAO Wanzhen, CUI Yanyan, ZHAO Jie, LIU Zhaoqiang, ZHAO Bojun. Research progress of diabetic macular ischaemia [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 130-136.
[6] HE Jing, LEI Chunyan, ZHANG Meixia. Association of glycosylated hemoglobin variation index with diabetic retinopathy severity [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 34-40.
[7] LUN Yingjun, CHEN Chen, GAO Hongcheng, FAN Qinglin, TAI Renqing. Role of Toll-like receptor 4/nuclear transcription factor-κB channels in diabetic retinopathy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 163-168.
[8] WANG Lixue, ZENG Yi, WANG Lixin, PENG Xianbing. Clinical observation of the effect of infiltrating Biprofen Gelatin Sponge after functional endoscopic sinus surgery [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 16-25.
[9] XU Enpei, SUN Xianyong. Diagnosis and treatment of exudative age-related macular degeneration combined with retinal pigment epithelial detachment [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(3): 125-142.
[10] TANG Huixin, LI Jingjing, ZOU Hong. Mechanism and clinical applications of subthreshold diode micropulse laser [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(3): 143-148.
[11] LIU Tong, LIN Wei, FENG Meng, YANG Yi, LIU Tingting, ZHANG Min. Analysis of the effect of berberine on diabetic retinopathy in the immune microenvironment based on network pharmacology and experimental verification [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(1): 94-104.
[12] WANG Luping, KOU Fangning, WANG Hao, ZHANG Canwei, WANG Yanling, YOU Ran, WU Weizhen. Effects of subretinal hyperreflective material on the visual prognosis of anti-VEGF therapy in patients with neovascular macular degeneration [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(6): 101-105.
[13] LI ManOverview,FENG Xue, WANG YanlingGuidance. Association between ocular ischemic syndrome and ischemic stroke [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 88-92.
[14] WANG Jiaojiao, LI MiaoOverview,SONG ZongmingGuidance. Progress in diabetic retinopathy mechanisms and cellular models [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 93-99.
[15] WANG Hui, WANG Jun, SUN Yi, YU Tengfei, ZHU Yuguang, ZHU Yan. Effect of intravitreal injection of HGF-MSCs on the expression of HGF in retina tissue of diabetic rats [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 72-77.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd